0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasmid Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24Q5634
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Plasmid Market Insights and Forecast to 2028
BUY CHAPTERS

Global Plasmid Market Research Report 2025

Code: QYRE-Auto-24Q5634
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plasmid Market

The global market for Plasmid was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Plasmid is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Plasmid is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Plasmid in Transfection is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Plasmid include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics, Copernicus Therapeutics Inc., Takara Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid.
The Plasmid market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasmid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Plasmid Market Report

Report Metric Details
Report Name Plasmid Market
Segment by Type
  • F-Plasmids
  • Col Plasmids
  • Resistance Plasmids
  • Cryptic Plasmids
  • Degradative Plasmids
  • Virulence Plasmids
Segment by Application
  • Transfection
  • Recombinant DNA Technology
  • Gene Therapy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics, Copernicus Therapeutics Inc., Takara Bio, InvivoGen, Miltenyi Biotec, Medigene Sdn Bhd, MaxCyte Inc., Mirus Bio LLC, MolMed S.p.A., GenePharma, Polyplus Transfection
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Plasmid company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Plasmid Market report?

Ans: The main players in the Plasmid Market are Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics, Copernicus Therapeutics Inc., Takara Bio, InvivoGen, Miltenyi Biotec, Medigene Sdn Bhd, MaxCyte Inc., Mirus Bio LLC, MolMed S.p.A., GenePharma, Polyplus Transfection

What are the Application segmentation covered in the Plasmid Market report?

Ans: The Applications covered in the Plasmid Market report are Transfection, Recombinant DNA Technology, Gene Therapy, Others

What are the Type segmentation covered in the Plasmid Market report?

Ans: The Types covered in the Plasmid Market report are F-Plasmids, Col Plasmids, Resistance Plasmids, Cryptic Plasmids, Degradative Plasmids, Virulence Plasmids

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 F-Plasmids
1.2.3 Col Plasmids
1.2.4 Resistance Plasmids
1.2.5 Cryptic Plasmids
1.2.6 Degradative Plasmids
1.2.7 Virulence Plasmids
1.3 Market by Application
1.3.1 Global Plasmid Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Transfection
1.3.3 Recombinant DNA Technology
1.3.4 Gene Therapy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Market Perspective (2020-2031)
2.2 Global Plasmid Growth Trends by Region
2.2.1 Global Plasmid Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plasmid Historic Market Size by Region (2020-2025)
2.2.3 Plasmid Forecasted Market Size by Region (2026-2031)
2.3 Plasmid Market Dynamics
2.3.1 Plasmid Industry Trends
2.3.2 Plasmid Market Drivers
2.3.3 Plasmid Market Challenges
2.3.4 Plasmid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Players by Revenue
3.1.1 Global Top Plasmid Players by Revenue (2020-2025)
3.1.2 Global Plasmid Revenue Market Share by Players (2020-2025)
3.2 Global Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plasmid Revenue
3.4 Global Plasmid Market Concentration Ratio
3.4.1 Global Plasmid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Revenue in 2024
3.5 Global Key Players of Plasmid Head office and Area Served
3.6 Global Key Players of Plasmid, Product and Application
3.7 Global Key Players of Plasmid, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Breakdown Data by Type
4.1 Global Plasmid Historic Market Size by Type (2020-2025)
4.2 Global Plasmid Forecasted Market Size by Type (2026-2031)
5 Plasmid Breakdown Data by Application
5.1 Global Plasmid Historic Market Size by Application (2020-2025)
5.2 Global Plasmid Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plasmid Market Size (2020-2031)
6.2 North America Plasmid Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plasmid Market Size by Country (2020-2025)
6.4 North America Plasmid Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid Market Size (2020-2031)
7.2 Europe Plasmid Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plasmid Market Size by Country (2020-2025)
7.4 Europe Plasmid Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Market Size (2020-2031)
8.2 Asia-Pacific Plasmid Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plasmid Market Size by Region (2020-2025)
8.4 Asia-Pacific Plasmid Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid Market Size (2020-2031)
9.2 Latin America Plasmid Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plasmid Market Size by Country (2020-2025)
9.4 Latin America Plasmid Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Market Size (2020-2031)
10.2 Middle East & Africa Plasmid Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plasmid Market Size by Country (2020-2025)
10.4 Middle East & Africa Plasmid Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aldevron
11.1.1 Aldevron Company Details
11.1.2 Aldevron Business Overview
11.1.3 Aldevron Plasmid Introduction
11.1.4 Aldevron Revenue in Plasmid Business (2020-2025)
11.1.5 Aldevron Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript Plasmid Introduction
11.2.4 GenScript Revenue in Plasmid Business (2020-2025)
11.2.5 GenScript Recent Development
11.3 PlasmidFactory GmbH & Co. KG
11.3.1 PlasmidFactory GmbH & Co. KG Company Details
11.3.2 PlasmidFactory GmbH & Co. KG Business Overview
11.3.3 PlasmidFactory GmbH & Co. KG Plasmid Introduction
11.3.4 PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2020-2025)
11.3.5 PlasmidFactory GmbH & Co. KG Recent Development
11.4 VGXI Inc.
11.4.1 VGXI Inc. Company Details
11.4.2 VGXI Inc. Business Overview
11.4.3 VGXI Inc. Plasmid Introduction
11.4.4 VGXI Inc. Revenue in Plasmid Business (2020-2025)
11.4.5 VGXI Inc. Recent Development
11.5 Oxford Genetics Ltd.
11.5.1 Oxford Genetics Ltd. Company Details
11.5.2 Oxford Genetics Ltd. Business Overview
11.5.3 Oxford Genetics Ltd. Plasmid Introduction
11.5.4 Oxford Genetics Ltd. Revenue in Plasmid Business (2020-2025)
11.5.5 Oxford Genetics Ltd. Recent Development
11.6 Applied StemCell
11.6.1 Applied StemCell Company Details
11.6.2 Applied StemCell Business Overview
11.6.3 Applied StemCell Plasmid Introduction
11.6.4 Applied StemCell Revenue in Plasmid Business (2020-2025)
11.6.5 Applied StemCell Recent Development
11.7 Altogen Biosystems
11.7.1 Altogen Biosystems Company Details
11.7.2 Altogen Biosystems Business Overview
11.7.3 Altogen Biosystems Plasmid Introduction
11.7.4 Altogen Biosystems Revenue in Plasmid Business (2020-2025)
11.7.5 Altogen Biosystems Recent Development
11.8 Cobra Biologics
11.8.1 Cobra Biologics Company Details
11.8.2 Cobra Biologics Business Overview
11.8.3 Cobra Biologics Plasmid Introduction
11.8.4 Cobra Biologics Revenue in Plasmid Business (2020-2025)
11.8.5 Cobra Biologics Recent Development
11.9 Copernicus Therapeutics Inc.
11.9.1 Copernicus Therapeutics Inc. Company Details
11.9.2 Copernicus Therapeutics Inc. Business Overview
11.9.3 Copernicus Therapeutics Inc. Plasmid Introduction
11.9.4 Copernicus Therapeutics Inc. Revenue in Plasmid Business (2020-2025)
11.9.5 Copernicus Therapeutics Inc. Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Plasmid Introduction
11.10.4 Takara Bio Revenue in Plasmid Business (2020-2025)
11.10.5 Takara Bio Recent Development
11.11 InvivoGen
11.11.1 InvivoGen Company Details
11.11.2 InvivoGen Business Overview
11.11.3 InvivoGen Plasmid Introduction
11.11.4 InvivoGen Revenue in Plasmid Business (2020-2025)
11.11.5 InvivoGen Recent Development
11.12 Miltenyi Biotec
11.12.1 Miltenyi Biotec Company Details
11.12.2 Miltenyi Biotec Business Overview
11.12.3 Miltenyi Biotec Plasmid Introduction
11.12.4 Miltenyi Biotec Revenue in Plasmid Business (2020-2025)
11.12.5 Miltenyi Biotec Recent Development
11.13 Medigene Sdn Bhd
11.13.1 Medigene Sdn Bhd Company Details
11.13.2 Medigene Sdn Bhd Business Overview
11.13.3 Medigene Sdn Bhd Plasmid Introduction
11.13.4 Medigene Sdn Bhd Revenue in Plasmid Business (2020-2025)
11.13.5 Medigene Sdn Bhd Recent Development
11.14 MaxCyte Inc.
11.14.1 MaxCyte Inc. Company Details
11.14.2 MaxCyte Inc. Business Overview
11.14.3 MaxCyte Inc. Plasmid Introduction
11.14.4 MaxCyte Inc. Revenue in Plasmid Business (2020-2025)
11.14.5 MaxCyte Inc. Recent Development
11.15 Mirus Bio LLC
11.15.1 Mirus Bio LLC Company Details
11.15.2 Mirus Bio LLC Business Overview
11.15.3 Mirus Bio LLC Plasmid Introduction
11.15.4 Mirus Bio LLC Revenue in Plasmid Business (2020-2025)
11.15.5 Mirus Bio LLC Recent Development
11.16 MolMed S.p.A.
11.16.1 MolMed S.p.A. Company Details
11.16.2 MolMed S.p.A. Business Overview
11.16.3 MolMed S.p.A. Plasmid Introduction
11.16.4 MolMed S.p.A. Revenue in Plasmid Business (2020-2025)
11.16.5 MolMed S.p.A. Recent Development
11.17 GenePharma
11.17.1 GenePharma Company Details
11.17.2 GenePharma Business Overview
11.17.3 GenePharma Plasmid Introduction
11.17.4 GenePharma Revenue in Plasmid Business (2020-2025)
11.17.5 GenePharma Recent Development
11.18 Polyplus Transfection
11.18.1 Polyplus Transfection Company Details
11.18.2 Polyplus Transfection Business Overview
11.18.3 Polyplus Transfection Plasmid Introduction
11.18.4 Polyplus Transfection Revenue in Plasmid Business (2020-2025)
11.18.5 Polyplus Transfection Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Plasmid Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of F-Plasmids
 Table 3. Key Players of Col Plasmids
 Table 4. Key Players of Resistance Plasmids
 Table 5. Key Players of Cryptic Plasmids
 Table 6. Key Players of Degradative Plasmids
 Table 7. Key Players of Virulence Plasmids
 Table 8. Global Plasmid Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Plasmid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Plasmid Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Plasmid Market Share by Region (2020-2025)
 Table 12. Global Plasmid Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Plasmid Market Share by Region (2026-2031)
 Table 14. Plasmid Market Trends
 Table 15. Plasmid Market Drivers
 Table 16. Plasmid Market Challenges
 Table 17. Plasmid Market Restraints
 Table 18. Global Plasmid Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Plasmid Market Share by Players (2020-2025)
 Table 20. Global Top Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2024)
 Table 21. Ranking of Global Top Plasmid Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Plasmid Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Plasmid, Headquarters and Area Served
 Table 24. Global Key Players of Plasmid, Product and Application
 Table 25. Global Key Players of Plasmid, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Plasmid Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Plasmid Revenue Market Share by Type (2020-2025)
 Table 29. Global Plasmid Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Plasmid Revenue Market Share by Type (2026-2031)
 Table 31. Global Plasmid Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Plasmid Revenue Market Share by Application (2020-2025)
 Table 33. Global Plasmid Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Plasmid Revenue Market Share by Application (2026-2031)
 Table 35. North America Plasmid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Plasmid Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Plasmid Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Plasmid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Plasmid Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Plasmid Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Plasmid Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Plasmid Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Plasmid Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Plasmid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Plasmid Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Plasmid Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Plasmid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Plasmid Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Plasmid Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Aldevron Company Details
 Table 51. Aldevron Business Overview
 Table 52. Aldevron Plasmid Product
 Table 53. Aldevron Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 54. Aldevron Recent Development
 Table 55. GenScript Company Details
 Table 56. GenScript Business Overview
 Table 57. GenScript Plasmid Product
 Table 58. GenScript Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 59. GenScript Recent Development
 Table 60. PlasmidFactory GmbH & Co. KG Company Details
 Table 61. PlasmidFactory GmbH & Co. KG Business Overview
 Table 62. PlasmidFactory GmbH & Co. KG Plasmid Product
 Table 63. PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 64. PlasmidFactory GmbH & Co. KG Recent Development
 Table 65. VGXI Inc. Company Details
 Table 66. VGXI Inc. Business Overview
 Table 67. VGXI Inc. Plasmid Product
 Table 68. VGXI Inc. Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 69. VGXI Inc. Recent Development
 Table 70. Oxford Genetics Ltd. Company Details
 Table 71. Oxford Genetics Ltd. Business Overview
 Table 72. Oxford Genetics Ltd. Plasmid Product
 Table 73. Oxford Genetics Ltd. Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 74. Oxford Genetics Ltd. Recent Development
 Table 75. Applied StemCell Company Details
 Table 76. Applied StemCell Business Overview
 Table 77. Applied StemCell Plasmid Product
 Table 78. Applied StemCell Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 79. Applied StemCell Recent Development
 Table 80. Altogen Biosystems Company Details
 Table 81. Altogen Biosystems Business Overview
 Table 82. Altogen Biosystems Plasmid Product
 Table 83. Altogen Biosystems Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 84. Altogen Biosystems Recent Development
 Table 85. Cobra Biologics Company Details
 Table 86. Cobra Biologics Business Overview
 Table 87. Cobra Biologics Plasmid Product
 Table 88. Cobra Biologics Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 89. Cobra Biologics Recent Development
 Table 90. Copernicus Therapeutics Inc. Company Details
 Table 91. Copernicus Therapeutics Inc. Business Overview
 Table 92. Copernicus Therapeutics Inc. Plasmid Product
 Table 93. Copernicus Therapeutics Inc. Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 94. Copernicus Therapeutics Inc. Recent Development
 Table 95. Takara Bio Company Details
 Table 96. Takara Bio Business Overview
 Table 97. Takara Bio Plasmid Product
 Table 98. Takara Bio Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 99. Takara Bio Recent Development
 Table 100. InvivoGen Company Details
 Table 101. InvivoGen Business Overview
 Table 102. InvivoGen Plasmid Product
 Table 103. InvivoGen Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 104. InvivoGen Recent Development
 Table 105. Miltenyi Biotec Company Details
 Table 106. Miltenyi Biotec Business Overview
 Table 107. Miltenyi Biotec Plasmid Product
 Table 108. Miltenyi Biotec Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 109. Miltenyi Biotec Recent Development
 Table 110. Medigene Sdn Bhd Company Details
 Table 111. Medigene Sdn Bhd Business Overview
 Table 112. Medigene Sdn Bhd Plasmid Product
 Table 113. Medigene Sdn Bhd Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 114. Medigene Sdn Bhd Recent Development
 Table 115. MaxCyte Inc. Company Details
 Table 116. MaxCyte Inc. Business Overview
 Table 117. MaxCyte Inc. Plasmid Product
 Table 118. MaxCyte Inc. Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 119. MaxCyte Inc. Recent Development
 Table 120. Mirus Bio LLC Company Details
 Table 121. Mirus Bio LLC Business Overview
 Table 122. Mirus Bio LLC Plasmid Product
 Table 123. Mirus Bio LLC Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 124. Mirus Bio LLC Recent Development
 Table 125. MolMed S.p.A. Company Details
 Table 126. MolMed S.p.A. Business Overview
 Table 127. MolMed S.p.A. Plasmid Product
 Table 128. MolMed S.p.A. Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 129. MolMed S.p.A. Recent Development
 Table 130. GenePharma Company Details
 Table 131. GenePharma Business Overview
 Table 132. GenePharma Plasmid Product
 Table 133. GenePharma Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 134. GenePharma Recent Development
 Table 135. Polyplus Transfection Company Details
 Table 136. Polyplus Transfection Business Overview
 Table 137. Polyplus Transfection Plasmid Product
 Table 138. Polyplus Transfection Revenue in Plasmid Business (2020-2025) & (US$ Million)
 Table 139. Polyplus Transfection Recent Development
 Table 140. Research Programs/Design for This Report
 Table 141. Key Data Information from Secondary Sources
 Table 142. Key Data Information from Primary Sources
 Table 143. Authors List of This Report


List of Figures
 Figure 1. Plasmid Picture
 Figure 2. Global Plasmid Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Plasmid Market Share by Type: 2024 VS 2031
 Figure 4. F-Plasmids Features
 Figure 5. Col Plasmids Features
 Figure 6. Resistance Plasmids Features
 Figure 7. Cryptic Plasmids Features
 Figure 8. Degradative Plasmids Features
 Figure 9. Virulence Plasmids Features
 Figure 10. Global Plasmid Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Plasmid Market Share by Application: 2024 VS 2031
 Figure 12. Transfection Case Studies
 Figure 13. Recombinant DNA Technology Case Studies
 Figure 14. Gene Therapy Case Studies
 Figure 15. Others Case Studies
 Figure 16. Plasmid Report Years Considered
 Figure 17. Global Plasmid Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Plasmid Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Plasmid Market Share by Region: 2024 VS 2031
 Figure 20. Global Plasmid Market Share by Players in 2024
 Figure 21. Global Top Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Plasmid Revenue in 2024
 Figure 23. North America Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Plasmid Market Share by Country (2020-2031)
 Figure 25. United States Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Plasmid Market Share by Country (2020-2031)
 Figure 29. Germany Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Plasmid Market Share by Region (2020-2031)
 Figure 37. China Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Plasmid Market Share by Country (2020-2031)
 Figure 45. Mexico Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Plasmid Market Share by Country (2020-2031)
 Figure 49. Turkey Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Plasmid Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Aldevron Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 53. GenScript Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 54. PlasmidFactory GmbH & Co. KG Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 55. VGXI Inc. Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 56. Oxford Genetics Ltd. Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 57. Applied StemCell Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 58. Altogen Biosystems Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 59. Cobra Biologics Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 60. Copernicus Therapeutics Inc. Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 61. Takara Bio Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 62. InvivoGen Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 63. Miltenyi Biotec Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 64. Medigene Sdn Bhd Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 65. MaxCyte Inc. Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 66. Mirus Bio LLC Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 67. MolMed S.p.A. Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 68. GenePharma Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 69. Polyplus Transfection Revenue Growth Rate in Plasmid Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String